POLE and endometrial carcinoma: Analysis of the TCGA endometrial carcinoma cohort using only ECs with a known pathogenic hotspot POLE-EDM as a “truth set” allowed the development of a scoring system, with well-defined cutoff points for examining pathogenicity of POLE variants (1, 2).